OpenAI’s cozy partner Cerebras is on track for a blockbuster IPO
AI chip maker Cerebras is heading for a blockbuster IPO that could value it at $26.6 billion or more. Its relationship with OpenAI is deep and rich.
Startups
Katie Haun raises $1B for new venture funds
Katie Haun announced on Monday that $1 billion has been raised across new funds to continue the firm’s thesis of backing crypto and blockchain startups.
5 days only: Bring a partner or colleague and get 50% off a second TechCrunch Disrupt 2026 pass
The BOGO offer is live. For a limited time, buy one pass to TechCrunch Disrupt 2026 and get 50% off a second of the same ticket type. Offer ends this Friday,…
‘This is fine’ creator says AI startup stole his art
The ad comes from Artisan, the AI startup behind billboards urging businesses to “stop hiring humans.”
Beyond Lovable and Mistral: 21 European startups to watch
It is not that European startups never get attention — Lovable and Mistral AI are proof of that. But there are many more that insiders are tracking.
Musk v. Altman is just getting started
Elon Musk spent the better part of three days on the witness stand this week in his lawsuit against OpenAI, and it’s already getting messy. Emails, texts, and his own tweets are surfacing in court, and there are…
Y Combinator alum Skio sells for $105M cash, only raised $8M, founder says
Subscription billing fintech Skio sold to its competitor Recharge in what was a healthy exit, according to its founder and former CEO.
Legal AI startup Legora hits $5.6 valuation and its battle with Harvey just got hotter
The two wildly fast-growing rivals have raised massive sums, pushed into each other’s home turf and now have dueling ad campaigns.
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
SpaceX backer 137 Ventures raises $700M for two growth-stage funds
VC firm 137 Ventures has raised over $700 million to back growth-stage startups. Its portfolio includes SpaceX, Anduril, Hadrian.